We have received text from H.R. 5605: Medical Device Nonvisual Accessibility Act of 2025. This bill was received on 2025-09-26, and currently has 15 cosponsors.
Here is a short summary of the bill:
This bill, known as the Medical Device Nonvisual Accessibility Act of 2025, aims to make medical devices with digital interfaces more accessible to individuals who are blind or have low vision. It addresses the growing complexity of user interfaces in medical devices, such as blood pressure monitors and sleep apnea machines, which are increasingly being used at home but are often difficult for visually impaired users to operate.
Key Provisions
- Nonvisual Accessibility Standards : The bill proposes new standards that require certain medical devices to have user interfaces that are equally effective for blind or low-vision individuals as they are for sighted users. This means that these individuals should be able to access information and perform tasks with similar privacy, independence, and ease of use.
- Waivers : The Secretary of Health and Human Services can waive these standards for a device if it is shown that adhering to them would fundamentally alter the device or cause undue hardship for the manufacturer.
- Training and Consultation : The bill mandates that training will be provided to manufacturers regarding compliance with these standards. Additionally, the Secretary will consult with organizations and individuals who are blind or have low vision during the development of these standards.
- Regulatory Timeline : The Secretary must propose regulations to implement these standards within one year of the bill's enactment and finalize those rules within two years, with the final rules taking effect one year after publication.
Definitions
The bill defines a "covered device" as a class II or III medical device that is not solely intended for healthcare provider use outside of a home setting and which has a digital user interface. Key terms related to the bill include:
- Fundamental Alteration : A change to the device that would render it unusable or incapable of performing its essential function.
- Undue Hardship : Significant difficulty or expense required for a manufacturer to comply with the standards, based on various factors like the overall financial resources of the manufacturer.
The overall intent of the bill is to enhance the usability of medical devices for individuals with visual impairments, promoting greater independence and safety when using such technologies at home.
Relevant Companies
- ABT (Abbott Laboratories): A manufacturer of medical devices such as glucose monitors which may need to adapt their interfaces to meet the new accessibility standards.
- MDT (Medtronic): Known for various medical devices, including insulin pumps and other home-use medical technologies that would need to comply with accessibility guidelines.
- BDX (Becton, Dickinson and Company): Engaged in developing medical devices that could also fall under the requirements of this legislation.
Representative Janice D. Schakowsky Bill Proposals
Here are some bills which have recently been proposed by Representative Janice D. Schakowsky:
- H.R.5605: Medical Device Nonvisual Accessibility Act of 2025
- H.R.5489: Future Generations Protection Act
- H.R.4725: TRUTH in Labeling Act
- H.R.4614: Franchisee Freedom Act
- H.R.4528: Price Gouging Prevention Act of 2025
- H.R.4436: Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2025
You can track bills proposed by Representative Janice D. Schakowsky on Quiver Quantitative's politician page for Schakowsky.
Representative Janice D. Schakowsky Net Worth
Quiver Quantitative estimates that Representative Janice D. Schakowsky is worth $586.0K, as of October 7th, 2025. This is the 386th highest net worth in Congress, per our live estimates.
Schakowsky has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Representative Janice D. Schakowsky's net worth on Quiver Quantitative's politician page for Schakowsky.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
